
Huma
Founded Year
2011Stage
Series D | AliveTotal Raised
$367.6MValuation
$0000Last Raised
$80M | 1 yr agoRevenue
$0000Mosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+76 points in the past 30 days
About Huma
Huma is a healthcare AI company that provides digital health solutions for care and research. The company offers services including remote patient monitoring, hospital-at-home programs, virtual wards, and decentralized clinical trials. Huma's technology is used by hospitals and clinics globally and is integrated into clinical trials. Huma was formerly known as Huma Therapeutics GmbH. It was founded in 2011 and is based in London, United Kingdom.
Loading...
Huma's Product Videos


ESPs containing Huma
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The digital biomarker monitoring market provides technology solutions that capture and analyze digital health data to assess and predict health outcomes. Utilizing devices and software that integrate into patients’ daily lives, these solutions monitor various physiological and behavioral indicators that serve as biomarkers for health conditions. This market includes mobile apps that track activity…
Huma named as Leader among 15 other companies, including Amazon, Oura, and Medidata.
Huma's Products & Differentiators
HumaWorkSpace
We have built the Huma Cloud Platform, a powerful tool that makes launching digital healthcare solutions 10x easier, faster, and more cost-effective. Think of the Huma Cloud Platform as Shopify for digital health a robust, customizable foundation that simplifies the complex landscape of digital health and regulated app development. With active registrations in 4 continents, HCP sets a new industry standard, ensuring that digital health applications can be deployed safely and efficiently across the US and global markets.
Loading...
Research containing Huma
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Huma in 16 CB Insights research briefs, most recently on Jul 3, 2025.

May 23, 2025
The AI in drug R&D market map
Oct 17, 2024 report
State of Digital Health Q3’24 Report

Aug 21, 2024
The clinical trials tech market mapExpert Collections containing Huma
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Huma is included in 6 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,276 items
AI 100 (All Winners 2018-2025)
100 items
Artificial Intelligence
12,322 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Value-Based Care & Population Health
1,069 items
The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.
Digital Health
11,408 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Telehealth
3,122 items
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Huma Patents
Huma has filed 7 patents.
The 3 most popular patent topics include:
- smartwatches
- medical equipment
- psychiatric diagnosis

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
2/6/2019 | Blood pressure, Arteries of the upper limb, Arteries of the head and neck, Vascular diseases, Hypertension | Application |
Application Date | 2/6/2019 |
---|---|
Grant Date | |
Title | |
Related Topics | Blood pressure, Arteries of the upper limb, Arteries of the head and neck, Vascular diseases, Hypertension |
Status | Application |
Latest Huma News
Jun 9, 2025
Huma Deploys Hi Scribe to Automate Clinical Documentation & Billing With AI June 9, 2025 Transforms clinical workflows by auto-generating structured medical notes and billing codes, seamlessly integrated into EHR systems from patient–doctor conversations. Already live across 870 practices and scaling globally through government and enterprise partnerships, including with Wheel. Huma Therapeutics, the global healthcare AI company, today announced the launch of Hi Scribe, a generative AI clinical documentation tool designed to automate and streamline the creation of clinical notes and supporting materials. Hi Scribe is built on top of the Huma AI foundation engine, known as Huma Intelligence (Hi), which also supports Hi Nurse (10X Nurse) and several other AI features. It is powered by insights from over 60 million consultations conducted by eConsult, one of Huma’s portfolio companies acquired last year. Available within the Huma Cloud Platform (HCP), Hi Scribe automates clinical documentation in real-time, automatically generates structured clinical notes and enables direct integration into electronic health record (EHR) systems. It is designed for both in-person and virtual care settings, supporting clinicians across the full spectrum of digital health delivery. Already launched in the UK to 870 practices (covering 10 million patients) with writeback and coding capabilities for EMIS and SystmOne, the technology leverages Huma’s strategic partnership with Google Cloud to deliver secure, scalable, and clinically compliant AI services to frontline healthcare workers. “Administrative burdens—from documentation to process compliance and accurate billing—are among the greatest challenges facing healthcare systems globally,” said Dan Vahdat, CEO and Founder of Huma. “Hi Scribe gives clinicians critical time back, allowing them to focus on what matters most: their patients. We’re excited to roll this out across the 4,500+ health systems and clinics powered by Huma technologies around the world.” Regulatory-Compliant, Clinically Integrated Hi Scribe fully complies with regulations set forth by the UK Medicines and Healthcare products Regulatory Agency (MHRA) as a medical device and is part of Huma’s globally compliant, enterprise-grade technology suite. It integrates directly into EHR systems, enabling clinicians to submit documentation seamlessly without disrupting workflow. As part of a broader care enablement strategy, Hi Scribe empowers clinicians with intelligent tools that reduce documentation burden while enhancing consistency and care quality. The launch follows recent NHS England guidance supporting the use of AI in clinical documentation and highlights Huma’s role in driving innovation across public and private healthcare systems. With documentation consuming up to a third of clinical time globally, Huma is expanding access to Hi Scribe across its international footprint, which includes over 70 countries and 50 million engaged individuals. “This tool brings clinicians’ attention back to their patients,” said Dr. Murray Ellender, Head of UK Healthcare, Huma. “By leveraging generative AI with strong regulatory governance, we are ensuring safe, effective, and efficient care. We are excited in the near future to start helping care providers with intelligent suggestions for next steps—ensuring that nothing is left unnoticed. We built this product in partnership with Opencast – a leading UK tech consultancy” “Using Hi Scribe to transcribe my medical notes has transformed my day—saving me 2-3 minutes every consultation, reducing pressure, and letting me focus fully on my patients.” said Dr Ross Dyer-Smith, NHS GP. “I have more headspace to think, listen, and make decisions. It’s brought back more of the most satisfying part of practicing medicine—truly engaging and connecting with my patients.” U.S. Expansion with Wheel Huma’s partner Wheel, the largest telemedicine provider-as-a-service platform in the U.S., will be among the first to bring Hi Scribe to virtual-first care environments in the U.S. through its Horizon platform. “Clinicians shouldn’t have to choose between delivering great care and managing documentation,” said Michelle Davey, CEO and Founder of Wheel. “At Wheel, we’re always looking for ways to make their jobs easier without adding friction. With Hi Scribe now integrated into Horizon, we’re excited to be among the first to bring this kind of transformative AI technology to virtual care in the U.S.— giving our partners and their patients a better experience.” As Wheel brings Hi Scribe to market, it will be made available to enterprise organizations and digital health partners, expanding access to AI-powered documentation across U.S. virtual care delivery. Nationwide Rollouts Huma has also partnered with several countries to roll out this technology across all clinics as part of government-led digital health initiatives. Capturing clinical notes and automatically entering them into EMR systems remains a major challenge for many countries striving to accelerate the digitalization of their healthcare infrastructure. GlobeNewswire GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public. previous post
Huma Frequently Asked Questions (FAQ)
When was Huma founded?
Huma was founded in 2011.
Where is Huma's headquarters?
Huma's headquarters is located at 21-24 Millbank, London.
What is Huma's latest funding round?
Huma's latest funding round is Series D.
How much did Huma raise?
Huma raised a total of $367.6M.
Who are the investors of Huma?
Investors of Huma include Leaps by Bayer, HAT, Hitachi Ventures, AstraZeneca, SBRI Healthcare and 17 more.
Who are Huma's competitors?
Competitors of Huma include Current Health, Verily, Lindus Health, Luscii, Albert Health and 7 more.
What products does Huma offer?
Huma's products include HumaWorkSpace and 2 more.
Who are Huma's customers?
Customers of Huma include UCB.
Loading...
Compare Huma to Competitors

Lindus Health conducts end-to-end clinical trials for the life sciences sector, using a technology-driven approach to streamline the process. The company provides services including study design, patient recruitment, clinical data capture, monitoring, and project management, facilitated by a proprietary software platform and access to electronic health records. It serves the biotechnology and pharmaceutical industries. The company was founded in 2021 and is based in London, United Kingdom.

Doccla is a virtual hospital that specializes in the healthcare technology sector. The company offers remote patient monitoring services, utilizing medical IoT devices to monitor patients outside of traditional hospital settings, and integrates with electronic health records to streamline patient data management. Doccla primarily serves the healthcare industry, providing solutions to hospitals, clinics, and other medical institutions. It was founded in 2019 and is based in London, United Kingdom.

Validic is a technology company specializing in health IoT platforms and EHR-integrated solutions for personalized remote patient care. The company offers a comprehensive ecosystem of connected health devices and apps, alongside an EHR-embedded application designed to make personal health data meaningful and actionable for clinicians and patients. Validic primarily serves the healthcare industry, including health systems, providers, payers, wellness companies, pharmaceuticals, health IT companies, and manufacturers of apps and devices. Validic was formerly known as Motivation Science. It was founded in 2010 and is based in Durham, North Carolina.

Evidation is involved in measuring health in everyday life within the digital health sector. The company provides a platform for individuals to track health activities, participate in research, and manage their data privacy. Evidation serves the life sciences, government, and non-profit organizations. It was founded in 2012 and is based in San Mateo, California.

BrightInsight is involved in digital health solutions. Its main offerings include a cloud-based platform that supports the development and scaling of companion applications, algorithms, connected combination products, and healthcare provider interfaces, all designed to function as software as a medical device (SaMD). BrightInsight serves life sciences companies that use digital health tools and real-world data. It was founded in 2017 and is based in Alviso, California.

Medable is a company that offers a cloud-based platform for decentralized clinical trial technology in the healthcare and clinical research sectors. The platform facilitates electronic Clinical Outcome Assessments (eCOA), remote monitoring, and the integration of connected healthcare sensors for clinical trials. Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.
Loading...